oncology

BMS UK recently announced that it would not longer be promoting Zeposia and Sotyktu. That means Innovative Medicines no longer exists as a BU, and they laid off ~30% of the UK staff. Of course the LT has taken care of their own as usual while other colleagues are pushed out. Oncology and...

Hi, everyone! To be honest, I work for a biopharma-centric market research firm and we want to know which market research firms or reports our current and potential clients like most...and least...specifically within oncology. Please let us know! Thanks.

Hello out there! I'm a 12-year cancer survivor trying to understand a bit more about the drug sales process for oncology. If anyone is willing to have a 15 minute call to answer a few questions, I'd appreciate it! Respond to this and we can connect!

Does anyone else feel that chatrick seems like a mortician, his dead pan scripted talks make feel like I am at a funeral! Problem is I don’t know whose funeral it is? So many people leaving oncology and he won’t address it. He needs to allow hq employees to work remotely without fear of...

Anyone got any news on oncology changes? I just heard a big re-org is coming.

I'm looking at a job with Onco 360, an oncology based Specialty Pharmacy. I was curious if anyone had heard anything good or bad about the company. Open, as well, to suggestions on good Specialty Pharmacy and Oncology based positions with Pharma companies. I've been in the industry for 10 years...

Doesn’t matter what division, it sucks. Let’s call it what it is, toxic, demoralizing, life suck place. Highest resignation #s in last year, home office should be embarrassed by but they blame people as disloyal traitors? Can’t wait to give my resignation, best Christmas gift ever for me & my...

I am hearing that this company might be the next big thing. Anyone?

VIRUSES Is it possible to think that we could engineer a virus to attack a specific cell group and destroy it? I believe it is since there are viruses that only attack certain cells of the body they developed they’re own way of identifying these cells and by doing so can start attacking a...

Bristol-Myers Squibb acquires Celgene for $74 billion. Celgene stock surges while BMY plunges. 2019 starts well for Celgene. More M&As are in the pipeline in the biopharma space.

What does everyone think of the goals set for us in Women’s Health? I think not possible and Fred needs to get a new strategy along with the AE in my territory who knows nothing. It is a shame they did not hire people with the skills sets needed to be successful.

what’s the salary range for the SEG Network Manager positions? Any insight?

In the past two weeks, Celgene has reported positive results from 3 clinical trials. This includes two studies with its partner Acceleron. https://news.alphastreet.com/celgene-gets-a-booster-shot-from-recent-positive-clinical-trial-results/

Does anyone have feedback on the Bayer Oncology contract...how secure is it, range of base?

In a deal aimed at expanding its oncology portfolio further, Eli Lilly will acquire cancer drug maker AurKa Pharma. The decision comes a few days after the pharma giant agreed to buy late-stage immune-oncology company ARMO Biosciences...

ARMO Biosciences loss in the fiscal year 2017 has increased compared to the fiscal year 2016. I don't know why Lilly is acquiring this loss making company. Will this acquisition really benefit Lilly? https://news.alphastreet.com/eli-lilly-acquires-armo-biosciences-strengthens-oncology-portfolio/

Celgene strengthens its cancer portfolio by acquiring Impact Biomedicines. After stopping the Crohn's disease treatment trials and cutting down the 2020 outlook recently, this deal is a positive news for Celgene. But Sanofi had sold the rights of fedrantinib to Impact in 2016 when the drug was...

Several new oncology sales positions open across the US. Does anyone know what drugs they will carry? Base pay and bonus ranges? Is it true that Lilly will pay 100% of your tuition?

http://alphastreet.com/b0662389 Celgene's outlook, especially it's long-term targets, is not an encouraging one. Also, a decrease in pharma company's research and development expenses is not a good sign.

Lilly signs a deal with Germany-based Curevac to strengthen its oncology division. http://alph.st/b72eaf5f